Bioelectronics Corp (BIEL)

[doc063]

I discussed the sale of Actipatch in major U S stores with AW a week ago based on earlier PR that the products would be in stores in September 2017. The feedback that I received from him was he does not think it will happen this year. He said the stores review their shelves once a year, and our next shot might be next year. I was not too happy about that because this product has so much potentials to help reduce the dependency on opioid medications.

He said he spent millions of his and family dollars on the products. But, I did not feel any sense of urgency about getting the products on the shelves from him. Just my opinion. Perhaps, he is waiting for a full FDA approval. It is a shame that other stocks are doing so well, even without any product to sell. But surprisingly, the stock price went from 0.0006 to 0.0008 the day after my conversation with AW. Pure coincidence? I really don't know.